Fevara PLC
02 October 2026
2 October 2026
Fevara plc
("Fevara", the "Group" or the "Company")
MelloMonday investor webinar
Fevara plc (LSE: FVA), an international specialist in livestock supplements, is pleased to announce that the Company will be attending MelloMonday on 5 October 2026 starting at 5.00pm, taking place via Zoom Webinar.
Joshua Hoopes, Chief Executive Officer and Gavin Manson, Chief Financial Officer will be presenting to webinar participants at 6.30pm and taking questions.
If you would like to attend, you can register for a free ticket with the code SHMM26 via the following link: www.tickettailor.com/events/melloeventslimited. The recording will be sent out to all registrants within 48 hours of the event.
For further information, please contact:
Enquiries
Fevara plc Joshua Hoopes, Chief Executive Officer Gavin Manson, Chief Financial Officer | +44 (0) 1228 554 600 |
Canaccord Genuity Limited (Corporate Broker) Max Hartley / Harry Rees | +44 (0)20 7523 8000 |
Hudson Sandler Wendy Baker / Nick Moore / Henry Mathieu | +44 (0) 20 7796 4133 |
About Fevara plc
Fevara is an international specialist in livestock supplements.
Fevara's purpose is to empower farmers in extensive grazing systems with research-proven products that boost profitability, improve resource efficiency and support sustainable agriculture. The Group develops, manufactures and markets research-proven supplements, including feed licks, blocks, bagged minerals, and boluses for cattle, sheep and horses, sold under recognised and trusted brands, including Crystalyx®, Horslic®, Horslyx®, Scotmin Nutrition®, SmartLic®, Tracesure® Advanced and Macal®.
Headquartered in Carlisle, Cumbria, in the UK, Fevara has manufacturing sites in the UK, US and Brazil with operational joint ventures in Germany and the US. It serves customers in more than 20 countries through its expansive international distribution and support network.
Fevara has been listed on the London Stock Exchange since 1972.
For more information, visit: www.fevara.com
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.